The cobalt-albumin binding assay: Insights into its mode of action

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 120-127

  Bar Or, David ^a   Rael, Leonard T ^a   Bar Or, Raphael ^a   Slone, Denetta S ^a   Mains, Charles W ^b   Rao, Nagaraja K R ^c   Curtis, C Gerald ^d  

^a SWEDISH MEDICAL CENTER   (United States)

^b St Anthony Central Hospital   (United States)

^c N N Scientific Ltd   (United Kingdom)

^d Bowman Research   (United States)

Author keywords

Albumin; Cobalt; Ischemia; Mass spectrometry; Plasma; Sulfhydryl compounds

Indexed keywords

COBALT; CYSTEINE; CYSTINE; HUMAN SERUM ALBUMIN; THIOL DERIVATIVE;

ACUTE HEART INFARCTION; ARTICLE; CASE REPORT; COMPLEX FORMATION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MASS SPECTROMETRY; PH; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COBALT; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN BINDING; SERUM ALBUMIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 35748962954     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.018     Document Type: Article

References (29)

1. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19 (2000) 311-315
2. Bar-Or D., Curtis G., Rao N., Bampos N., and Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 268 (2001) 42-47
3. Bar-Or D., Winkler J.V., Vanbenthuysen K., Harris L., Lau E., and Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
4. Can M., Demirtas S., Polat O., and Yildiz A. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 23 (2006) 537-539
5. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470
6. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., and Kaski J.C. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
7. Apple F.S. Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test. Adv Clin Chem 39 (2005) 1-10
8. Immanuel S., and Sanjaya A.I. Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome. Acta Med Indones 38 (2006) 92-96
9. Keating L., Benger J.R., Beetham R., et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23 (2006) 764-768
10. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. Cmaj 172 (2005) 1685-1690
11. Sadler P.J., Tucker A., and Viles J.H. Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+. Eur J Biochem 220 (1994) 193-200
12. Bar-Or D., Bar-Or R., Rael L.T., Gardner D.K., Slone D.S., and Craun M.L. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 33 (2005) 1638-1641
13. Barnhart J.L., and Berk R.N. Influence of paramagnetic ions and pH on proton NMR relaxation of biologic fluids. Invest Radiol 21 (1986) 132-136
14. Liang H., Huang J., Tu C.Q., Zhang M., Zhou Y.Q., and Shen P.W. The subsequent effect of interaction between Co(2+) and human serum albumin or bovine serum albumin. J Inorg Biochem 85 (2001) 167-171
15. Cobbe S.M., and Poole-Wilson P.A. The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol 12 (1980) 745-760
16. Mothes E., and Faller P. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry 46 (2007) 2267-2274
17. Berenshtein E., Mayer B., Goldberg C., Kitrossky N., and Chevion M. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 29 (1997) 3025-3034
18. Chevion M., Jiang Y., Har-El R., Berenshtein E., Uretzky G., and Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc Natl Acad Sci U S A 90 (1993) 1102-1106
19. Yukl R.L., Bar-Or D., Harris L., Shapiro H., and Winkler J.V. Low albumin level in the emergency department: a potential independent predictor of delayed mortality in blunt trauma. J Emerg Med 25 (2003) 1-6
20. Suliman M.E., Filho J.C., Barany P., Anderstam B., Lindholm B., and Bergstrom J. Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients. Nephrol Dial Transplant 16 (2001) 102-110
21. Verlaan M., Roelofs H.M., van-Schaik A., et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol 12 (2006) 5705-5710
22. Jones D.P., Carlson J.L., Samiec P.S., et al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 275 (1998) 175-184
23. Moriarty-Craige S.E., Adkison J., Lynn M., et al. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am J Ophthalmol 140 (2005) 1020-1026
24. Bar-Or D., Curtis C.G., Sullivan A., et al. Plasma albumin cysteinylation is regulated by cystathionine beta-synthase. Biochem Biophys Res Commun 325 (2004) 1449-1453
25. Bar-Or D., Heyborne K.D., Bar-Or R., Rael L.T., Winkler J.V., and Navot D. Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn 25 (2005) 245-249
26. Bar-Or D., Rael L.T., Thomas G.W., and Kraus J.P. Inhibitory effect of copper on cystathionine beta-synthase activity: protective effect of an analog of the human albumin N-terminus. Protein Pept Lett 12 (2005) 271-273
27. Carballal S., Radi R., Kirk M.C., Barnes S., Freeman B.A., and Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 42 (2003) 9906-9914
28. Simard J.R., Zunszain P.A., Ha C.E., et al. Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. Proc Natl Acad Sci U S A 102 (2005) 17958-17963
29. Ferri N., Paoletti R., and Corsini A. Lipid-modified proteins as biomarkers for cardiovascular disease: a review. Biomarkers 10 (2005) 219-237